Spyre Therapeutics, Inc.SYRENASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-198.04%
↑ 90% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineStrong
Average
-2084.14%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -198.04% | - |
| 2024 | 0.00% | +100.0% |
| 2023 | -14401.81% | -305.0% |
| 2022 | -3555.90% | -940.0% |
| 2021 | -341.92% | - |
| 2020 | 0.00% | +100.0% |
| 2018 | -1161.78% | -120.5% |
| 2017 | -526.94% | -12.0% |
| 2016 | -470.48% | -155.0% |
| 2015 | -184.49% | - |